Netherlands· NL-c55b6e839675
Akineton, tabletten 2 mg
A biperiden product containing biperideenhydrochloride, registered in Netherlands by Laboratorio Farmaceutico SIT S.r.l. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Biperiden is registered in 15 of 19 countries.
Countries holding a registration under ATC N04AA02 (biperiden), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Biperiden · ATC N04AA02
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of biperiden costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.28 in France to $1.58 in Switzerland — a ×5.7 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Biperiden · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.58
- IT Italy$0.36
- FR France$0.28
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BIPERIDEENHYDROCHLORIDE
- Manufacturer
- Laboratorio Farmaceutico SIT S.r.l
- Country
- Netherlands (NL)
- ATC code
- N04AA02
- ATC class
- Biperiden
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id02196
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for biperiden.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Biperiden · interactions on record
89 records
- 3 severe
- 85 moderate
- 1 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DicycloverineA03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Biperiden in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAkinetonDelfarma Sp. z o.o.
- United KingdomAkineton 2mg tabletsAbbott Laboratories Ltd
- FinlandAkinetonLaboratorio Farmaceutico S.I.T S.r.l.
- CzechiaAKINETONLaboratorio Farmaceutica S.I.T S.r.l, Mede (PV)
- NorwayAkinetonLaboratorio Farmaceutica S.I.T. Srl
- SwitzerlandAkineton
- SwedenAkineton 2 mg TablettLaboratorio Farmaceutico S.I.T. Srl
- SpainAKINETON 2 mg COMPRIMIDOSLaboratorio Farmaceutico S.I.T. - Specialita' Igienico Terapeutiche S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Akineton
- Belgium · Akineton
- Bulgaria · Акинестат, Акинетон
- Cyprus · Akineton Retard
- Czechia · Akineton
- Germany · Akineton, Biperiden Neuraxpharm
- Denmark · Akineton
- Spain · Akinetón, Akinetón Retard
- Finland · Akineton
- France · Akineton L.P.
- Greece · Akineton
- Croatia · Akineton, Mendilex
- Hungary · Akineton
- Ireland · Akineton, Akineton Retard
- Iceland · Akineton
- Italy · Akineton
- Luxembourg · Akineton
- Norway · Akineton
- Poland · Akineton, Akineton Sr
- Portugal · Akineton, Akineton Retard
- Sweden · Akineton
- Slovenia · Akineton
- Slovakia · Akineton, Akineton Sr
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/845db2a3-57bf-4494-952d-8690bdacd3a6 GET /v1/drugs/845db2a3-57bf-4494-952d-8690bdacd3a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h02196_smpc.pdf",
"strength": null,
"atc_label": "Biperiden",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg02196",
"excipients": [
"AARDAPPELZETMEEL",
"CALCIUMWATERSTOFFOSFAAT 2-WATER (E 341)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"COPOVIDON (E 1208)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"TALK (E 553b)"
],
"substances": [
"BIPERIDEENHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h02196.pdf",
"authorised_at": "1977/11/25",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "02196",
"additional_monitoring": "N"
}See everything about biperiden.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.